Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How Rheumatism Got its Name

Simon M. Helfgott, MD  |  Issue: March 2014  |  March 1, 2014

Needless to say, I was delighted to hear of the recent demise of the word rheumatism. For those of you who may be unaware, our lead journal, A&R, is now referred to as Arthritis & Rheumatology. I wish I could say that the word lived beyond its usefulness, but I doubt that it ever served any useful purpose. Rheumatology has replaced rheumatism. Hallelujah! Are we making progress? I need to ruminate on this development for a while.


Dr. Helfgott is physician editor of The Rheumatologist and associate professor of medicine in the division of rheumatology, immunology, and allergy at Harvard Medical School in Boston.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Helfgott SM. Pedal gangrene caused by giant cell arteritis. Arthritis Rheum. 1987;30:1078-1079.
  2. Parish LC. A historical approach to the nomenclature of rheumatoid arthritis. Arthritis Rheum. 1963;6:138-158.
  3. Rodnan GP. Growth and development of rheumatology in the United States—a bicentennial report. Arthritis Rheum. 1977;20:1149-1168.
  4. Kahn MF. Landré-Beauvais. Joint Bone Spine. 2001;68:143.
  5. Smith CD, Cyr M. The history of lupus erythematosus. From Hippocrates to Osler. Rheum Dis Clin North Am. 1988;14:1-14.
  6. Savin, JA. Osler and the skin. Brit J Derm. 2000;143:1-8.
  7. McCarty D, O’Duffy D, Pearson L, Hunter J. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA. 1985;254:2763-2767.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Career DevelopmentEducation & TrainingOpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)EducationGiant Cell ArteritisHelfgottHistoryPolymyalgia RheumaticaRheumatoid arthritisrheumatologistSystemic lupus erythematosus

Related Articles

    Cutaneous Lupus Tied to Risk for Coexisting Autoimmune Conditions

    May 10, 2018

    NEW YORK (Reuters Health)—Patients with cutaneous lupus erythematosus (CLE) should be monitored closely for other autoimmune conditions, researchers suggest. Dr. Benjamin Chong, Dr. Linda Hynan and Elaine Kunzler of the University of Texas Southwestern Medical Center in Dallas analyzed data from 129 adults in the UTSW Cutaneous Lupus Registry (mean age, 49; 79% women). Individuals…

    ARHP Angle: We Need a Few Good Leaders!

    August 1, 2009

    Flying back from Cincinnati, where I’d been attending a meeting of the ARHP Committee on Nominations, it occurred to me that some members might be intrigued by the process of how ARHP officers and committee and subcommittee chairs are selected. While I do realize that some members aren’t interested in the structural organization of ARHP, I know some may ask, “Why was she selected and not me?”

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

    License to Cure: Greed, Politics & Medical Licensure in the U.S.

    October 7, 2022

    William Osler, MD, had an idea. Many institutions lay claim to the legacy of Osler, and by the time he arrived at Johns Hopkins Hospital in 1889 to become the first physician in chief of the institution, he was already widely acknowledged for his clinical acumen. He now wanted to spread that clinical acumen around.1…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences